Kengo Takishima

Kengo Takishima is an accomplished executive with extensive experience in corporate strategy and management. Since August 2016, Kengo has served as both Chief Executive Officer and Chief Operating Officer at Baylor Genetics. Previously, Kengo held the role of General Manager at H.U. Groups Holdings Inc. from October 2013 to June 2023, where responsibilities included corporate strategy. Other notable positions include Board Director at Miraca Life Sciences and Chief Financial Officer at Baylor Genetics. Kengo's career also includes experience at GE Capital in sales and marketing, Executive Director at Kaleido Holdings in private equity, and Senior Associate in LBO finance at Mizuho Financial Group. Kengo's educational background comprises advanced management training at Harvard Business School, a global health care leaders program at Harvard Medical School, and degrees in international relations, business administration, genetics and genomics, and law from prestigious institutions.